A Study to Test the Safety of Pozelimab in Pediatric Participants 1 to 5 Years of Age With a Rare Disease Called CHAPLE (Complement Hyperactivation, Angiopathic Thrombosis, Protein-losing Enteropathy) Disease
Clinical trial NCT07142343 · RECRUITING
Trial details
- NCT number
- NCT07142343
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-19
- Primary completion
- 2030-02-12
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.